Medical Cannabis Payment Solutions, Inc.
33GN
Recommendation
--
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2017 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | -51.02% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -51.02% | ||||
| Operating Income | 51.02% | ||||
| Income Before Tax | 45.54% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 45.54% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 96.88% | ||||
| EBIT | 51.02% | ||||
| EBITDA | 57.29% | ||||
| EPS Basic | 100.00% | ||||
| Normalized Basic EPS | -- | ||||
| EPS Diluted | 100.00% | ||||
| Normalized Diluted EPS | -- | ||||
| Average Basic Shares Outstanding | 31.30% | ||||
| Average Diluted Shares Outstanding | 31.30% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||
